Ekaterina G. Seliverstova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ekaterina G. Seliverstova has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail Vladimirovich Sinkin
N.I. Pirogov Russian National Research Medical University; N.V. Sklifosovsky Scientific Research Institute of Emergency Medicine of the Moscow City Health Department
13 shared publications - Andrey Anatolievich Grin
Department of Neurosurgery, Sklifosovsky Research Institute for Emergency Medicine, Moscow, Russia
11 shared publications - Anton Yuryevich Kordonskiy
Department of Neurosurgery, Sklifosovsky Research Institute for Emergency Medicine, Moscow, Russia
5 shared publications - Lesya B. Zavaliy
Sklifosovsky Research Institute of Emergency Care
4 shared publications - Ganipa Ramazanovich Ramazanov
N.V. Sklifosovsky Research Institute for Emergency Medicine
3 shared publications - Sergey Petrikov
N.V. Sklifosovsky Research Institute for Emergency Medicine
3 shared publications
Latest Publications
- 13 November 2026
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 16 (3)
Botulinum toxin type A in facial palsy: a narrative review of current evidence
The aim of the work is to summarize and critically analyze current evidence on the use of botulinum toxin type A in facial nerve palsy. A narrative review of the literature published between 2022 and 2026 was conducted, focusing on mechanisms of action, application in acute and chronic phases, clinical protocols, safety, and impact on quality of life. Literature search was performed in PubMed, Scopus, and eLIBRARY databases, but a formal PRISMA-based selection was not applied. More than 30 studies were analyzed, including systematic reviews, meta-analyses, randomized and observational studies, as well as clinical guidelines. Priority was given to studies with higher levels of evidence and clinical relevance. In the acute phase, contralateral injections of botulinum toxin type A may improve facial symmetry and accelerate functional recovery. Early initiation of therapy is associated with better functional outcomes. In the chronic phase, botulinum therapy is effective in the management of synkinesis. Botulinum toxin type A represents an effective and safe therapeutic option for facial nerve palsy at different stages of the disease. The findings may be useful for the development of clinical protocols and personalized treatment strategies in patients with facial nerve palsy.
- 13 November 2026
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 16 (3)
Botulinum toxin type A in facial palsy: a narrative review of current evidence
The aim of the work is to summarize and critically analyze current evidence on the use of botulinum toxin type A in facial nerve palsy. A narrative review of the literature published between 2022 and 2026 was conducted, focusing on mechanisms of action, application in acute and chronic phases, clinical protocols, safety, and impact on quality of life. Literature search was performed in PubMed, Scopus, and eLIBRARY databases, but a formal PRISMA-based selection was not applied. More than 30 studies were analyzed, including systematic reviews, meta-analyses, randomized and observational studies, as well as clinical guidelines. Priority was given to studies with higher levels of evidence and clinical relevance. In the acute phase, contralateral injections of botulinum toxin type A may improve facial symmetry and accelerate functional recovery. Early initiation of therapy is associated with better functional outcomes. In the chronic phase, botulinum therapy is effective in the management of synkinesis. Botulinum toxin type A represents an effective and safe therapeutic option for facial nerve palsy at different stages of the disease. The findings may be useful for the development of clinical protocols and personalized treatment strategies in patients with facial nerve palsy.
- 23 October 2026
- Published by Science and Innovation Center
Facial nerve neuropathy following neurosurgical treatment of space-occupying lesions in the cerebellopontine angle
В учебно-методическом пособии представлены базовые принципы клинико-инструментальной диагностики поражения лицевого нерва после удаления опухоли мостомозжечкового угла, а также основные подходы к консервативному и хирургическому лечению. Пособие базируется на клинических рекомендациях, справочной литературе. Для нейрохирургов, неврологов, реабилитологов, врачей функциональной диагностики (нейрофизиологов).
- 23 October 2026
- Published by Science and Innovation Center
Facial nerve neuropathy following neurosurgical treatment of space-occupying lesions in the cerebellopontine angle
В учебно-методическом пособии представлены базовые принципы клинико-инструментальной диагностики поражения лицевого нерва после удаления опухоли мостомозжечкового угла, а также основные подходы к консервативному и хирургическому лечению. Пособие базируется на клинических рекомендациях, справочной литературе. Для нейрохирургов, неврологов, реабилитологов, врачей функциональной диагностики (нейрофизиологов).
- Open Access
- 15 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1982862
Inter-rater reliability of needle EMG pattern classification among physicians
Objective: To evaluate the inter-rater reliability of needle electromyographic (EMG) assessment among 19 physicians with varying clinical experience and specialties using a consensus standard as reference. Methods: The study followed the GRRAS guidelines. First, four EMG experts agreed on classifying thirty EMG recordings as normal, myogenic, or neurogenic and referred to as a consensus standard (CS). Second, those anonymised recordings were independently classified by 19 non-expert physicians. Thereafter, Cohen’s kappa (κ) was calculated for each physician against the CS. Fleiss’ κ was used for multi-rater agreement. Category-specific (one-vs-rest) κ, sensitivity and specificity were computed. Subgroup analyses by experience and specialty were performed. Post-hoc power analysis was used for the specialty comparison. Results: The mean κ versus the consensus standard across all physicians was 0.688 (median 0.747, SD 0.172; range 0.287–0.900). Overall multi-rater agreement (Fleiss’ κ) was 0.581. Category-specific κ values were: neurogenic 0.723, normal 0.368, myogenic 0.334. Sensitivity/specificity: neurogenic 94.6%/87.1%, myogenic 69.7%/96.1%, normal 78.2%/88.9%. Agreement with the CS increased with experience: mean κ rose from 0.365 (group 1, ≤1 year) to 0.798 (group 4, >10 years). No significant difference was found between neurologists and clinical physiologists (Mann–Whitney U, p = 0.174); post-hoc power was low (≈45%), thus non-significance should not be interpreted as equivalence. EMG experts showed almost perfect agreement ( κ = 0.85–0.95). Conclusion: In this exploratory study, physicians demonstrated moderate to substantial agreement with a CS standard in EMG classification. Neurogenic changes are identified most reliably, whereas differentiation between normal and myogenic changes remains challenging. Greater experience was associated with better agreement in our sample, but this finding requires confirmation in larger studies. No statistically significant difference was found between neurologists and clinical physiologists, although the analysis was underpowered. Individual competency varied widely within specialties, suggesting that objective, competency-based qualification may be more relevant than specialty alone.
- 15 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1982862
Open AccessInter-rater reliability of needle EMG pattern classification among physicians
Objective: To evaluate the inter-rater reliability of needle electromyographic (EMG) assessment among 19 physicians with varying clinical experience and specialties using a consensus standard as reference. Methods: The study followed the GRRAS guidelines. First, four EMG experts agreed on classifying thirty EMG recordings as normal, myogenic, or neurogenic and referred to as a consensus standard (CS). Second, those anonymised recordings were independently classified by 19 non-expert physicians. Thereafter, Cohen’s kappa (κ) was calculated for each physician against the CS. Fleiss’ κ was used for multi-rater agreement. Category-specific (one-vs-rest) κ, sensitivity and specificity were computed. Subgroup analyses by experience and specialty were performed. Post-hoc power analysis was used for the specialty comparison. Results: The mean κ versus the consensus standard across all physicians was 0.688 (median 0.747, SD 0.172; range 0.287–0.900). Overall multi-rater agreement (Fleiss’ κ) was 0.581. Category-specific κ values were: neurogenic 0.723, normal 0.368, myogenic 0.334. Sensitivity/specificity: neurogenic 94.6%/87.1%, myogenic 69.7%/96.1%, normal 78.2%/88.9%. Agreement with the CS increased with experience: mean κ rose from 0.365 (group 1, ≤1 year) to 0.798 (group 4, >10 years). No significant difference was found between neurologists and clinical physiologists (Mann–Whitney U, p = 0.174); post-hoc power was low (≈45%), thus non-significance should not be interpreted as equivalence. EMG experts showed almost perfect agreement ( κ = 0.85–0.95). Conclusion: In this exploratory study, physicians demonstrated moderate to substantial agreement with a CS standard in EMG classification. Neurogenic changes are identified most reliably, whereas differentiation between normal and myogenic changes remains challenging. Greater experience was associated with better agreement in our sample, but this finding requires confirmation in larger studies. No statistically significant difference was found between neurologists and clinical physiologists, although the analysis was underpowered. Individual competency varied widely within specialties, suggesting that objective, competency-based qualification may be more relevant than specialty alone.
- 11 February 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (1) , 100-107
Facial neuropathy in early postoperative period after resection of cerebellopontine angle tumor using various modalities of intraoperative neurophysiological monitoring: a systematic review and meta-analysis
Objective. To analyze the incidence of facial neuropathy after microsurgical resection of cerebellopontine angle (CPA) tumors using various intraoperative neurophysiological monitoring (IONM) scenarios. Material and methods. We analyzed 792 articles from PubMed, Google Scholar, Web of Science, and e-library databases and selected 35 eligible studies. There were 4.657 patients including 1.173 ones with facial neuropathy after CPA tumor resection. Statistical analysis was performed using OpenMeta Analyst software. Differences were significant at p< 0.05. Results. The pooled incidence of postoperative facial neuropathy after CPA tumor resection was 28.9% (95% CI: 23.3% — 34.6%). In case of multimodal IONM, this value decreased to 23.5% (95% CI: 17.9% — 29.2%). This demonstrates significant effectiveness of this approach compared to direct facial nerve stimulation and resting EMG monitoring.
- 11 February 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (1) , 100-107
Facial neuropathy in early postoperative period after resection of cerebellopontine angle tumor using various modalities of intraoperative neurophysiological monitoring: a systematic review and meta-analysis
Objective. To analyze the incidence of facial neuropathy after microsurgical resection of cerebellopontine angle (CPA) tumors using various intraoperative neurophysiological monitoring (IONM) scenarios. Material and methods. We analyzed 792 articles from PubMed, Google Scholar, Web of Science, and e-library databases and selected 35 eligible studies. There were 4.657 patients including 1.173 ones with facial neuropathy after CPA tumor resection. Statistical analysis was performed using OpenMeta Analyst software. Differences were significant at p< 0.05. Results. The pooled incidence of postoperative facial neuropathy after CPA tumor resection was 28.9% (95% CI: 23.3% — 34.6%). In case of multimodal IONM, this value decreased to 23.5% (95% CI: 17.9% — 29.2%). This demonstrates significant effectiveness of this approach compared to direct facial nerve stimulation and resting EMG monitoring.
- Open Access
- 26 June 2025
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 19 (2) , 52-61
Incidence of Facial Palsy Following Microsurgical Removal of Vestibular Schwannoma Using Direct Electrical Stimulation: a Meta-Analysis
Aim. To determine the incidence of facial palsy (FP) following microsurgical removal of vestibular schwannoma using direct electrical stimulation. Materials and methods. The meta-analysis included 946 publications from PubMed, Google Scholar, Web of Science, and eLIBRARY.RU, of which 9 studies meeting the inclusion and exclusion criteria were selected. The total number of patients was 1875, with 278 having FP after microsurgical removal of vestibular schwannoma. The pooled mean age of patients was 46.9 [44.5; 49.4] years, with a male-to-female ratio of 1 : 1. Results. The pooled incidence rate of early postoperative FP was 16.1% (6.8–25.3%), and delayed FP was 8.7% (0.5–12.4%). At 12 months postoperatively, patients with delayed FP demonstrated better recovery outcomes of facial muscle function.
- 26 June 2025
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 19 (2) , 52-61
Open AccessIncidence of Facial Palsy Following Microsurgical Removal of Vestibular Schwannoma Using Direct Electrical Stimulation: a Meta-Analysis
Aim. To determine the incidence of facial palsy (FP) following microsurgical removal of vestibular schwannoma using direct electrical stimulation. Materials and methods. The meta-analysis included 946 publications from PubMed, Google Scholar, Web of Science, and eLIBRARY.RU, of which 9 studies meeting the inclusion and exclusion criteria were selected. The total number of patients was 1875, with 278 having FP after microsurgical removal of vestibular schwannoma. The pooled mean age of patients was 46.9 [44.5; 49.4] years, with a male-to-female ratio of 1 : 1. Results. The pooled incidence rate of early postoperative FP was 16.1% (6.8–25.3%), and delayed FP was 8.7% (0.5–12.4%). At 12 months postoperatively, patients with delayed FP demonstrated better recovery outcomes of facial muscle function.
- Open Access
- 18 March 2025
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 61 (1)
Predicted time for radicular pain relief after microsurgical lumbar spinal nerve root decompression
Background: The exact time frame for RP relief following surgery and clinical, radiological and neurophysiological predictors of pain persistence after surgery are not clear. Results: Complete resolution of RP following MDSR was observed in 50 (86%) patients, with 24 (48%) reporting no pain on the first postoperative day. RP persisted for up to 4 weeks in 16 (32%) patients, up to 6 weeks in two (4%), and up to 8 and 12 weeks in four (8%). Sensory loss before surgery is a major adverse factor. Preoperative RP severity also played a negative role. However, paramedian herniation and a longer duration of the disease were associated with a shorter time to pain relief. Based on Fisher’s Linear Discriminant Analysis (FLDA) results, sex, age, extent of FI of the PM, and ODI (Oswestry Disability Index) score before surgery did not influence the outcome. Conclusions: In an overwhelming majority of cases, RP is completely resolved within the first 4 weeks following MDSR. The paramedian type of IVD herniation is the most favorable for RP relief. Sensory loss and severe pain before surgery result in persistent RP after MDSR. The time to RP relief in patients with identified EMG neurogenic findings in the PM was significantly shorter.
- 18 March 2025
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 61 (1)
Open AccessPredicted time for radicular pain relief after microsurgical lumbar spinal nerve root decompression
Background: The exact time frame for RP relief following surgery and clinical, radiological and neurophysiological predictors of pain persistence after surgery are not clear. Results: Complete resolution of RP following MDSR was observed in 50 (86%) patients, with 24 (48%) reporting no pain on the first postoperative day. RP persisted for up to 4 weeks in 16 (32%) patients, up to 6 weeks in two (4%), and up to 8 and 12 weeks in four (8%). Sensory loss before surgery is a major adverse factor. Preoperative RP severity also played a negative role. However, paramedian herniation and a longer duration of the disease were associated with a shorter time to pain relief. Based on Fisher’s Linear Discriminant Analysis (FLDA) results, sex, age, extent of FI of the PM, and ODI (Oswestry Disability Index) score before surgery did not influence the outcome. Conclusions: In an overwhelming majority of cases, RP is completely resolved within the first 4 weeks following MDSR. The paramedian type of IVD herniation is the most favorable for RP relief. Sensory loss and severe pain before surgery result in persistent RP after MDSR. The time to RP relief in patients with identified EMG neurogenic findings in the PM was significantly shorter.
- Open Access
- 13 February 2025
- Published by Frontiers Media SA in Frontiers in Musculoskeletal Disorders
- Vol. 3, 1528162
Lumbosacral plexopathy following alcohol-induced rhabdomyolysis: a case report
Objective: We present a rare case of lumbosacral plexopathy secondary to alcohol-induced rhabdomyolysis.Case description: A 58-year-old male patient was admitted to the intensive care unit (ICU). He reported a sensation of weakness in both legs and a tingling sensation in his feet upon awakening post binge drinking. Magnetic resonance imaging (MRI) of the thoracic and lumbar spine did not reveal any intraspinal abnormalities. However, an MRI showed lesions with abnormal intensities in both paraspinal muscles. Serum creatine phosphokinase level was markedly elevated. A diagnosis of lumbosacral plexopathy following alcohol-induced rhabdomyolysis was determined by clinical findings, MRI data and an electrophysiological evaluation. Upon discharge, lower limb strength was significantly improved.Discussion: In severe rhabdomyolysis, the resulting kidney injury and electrolyte imbalances can lead to systemic complications, including peripheral neuropathy or plexopathy. The exact mechanisms by which this occurs are not fully understood, however it is believed that the accumulation of toxic substances, electrolyte imbalances, and metabolic disturbances can contribute to nerve damage and dysfunction. Therefore, lumbosacral plexopathy should be included in the differential diagnosis of such cases, presenting with sudden leg weakness.
- 13 February 2025
- Published by Frontiers Media SA in Frontiers in Musculoskeletal Disorders
- Vol. 3, 1528162
Open AccessLumbosacral plexopathy following alcohol-induced rhabdomyolysis: a case report
Objective: We present a rare case of lumbosacral plexopathy secondary to alcohol-induced rhabdomyolysis.Case description: A 58-year-old male patient was admitted to the intensive care unit (ICU). He reported a sensation of weakness in both legs and a tingling sensation in his feet upon awakening post binge drinking. Magnetic resonance imaging (MRI) of the thoracic and lumbar spine did not reveal any intraspinal abnormalities. However, an MRI showed lesions with abnormal intensities in both paraspinal muscles. Serum creatine phosphokinase level was markedly elevated. A diagnosis of lumbosacral plexopathy following alcohol-induced rhabdomyolysis was determined by clinical findings, MRI data and an electrophysiological evaluation. Upon discharge, lower limb strength was significantly improved.Discussion: In severe rhabdomyolysis, the resulting kidney injury and electrolyte imbalances can lead to systemic complications, including peripheral neuropathy or plexopathy. The exact mechanisms by which this occurs are not fully understood, however it is believed that the accumulation of toxic substances, electrolyte imbalances, and metabolic disturbances can contribute to nerve damage and dysfunction. Therefore, lumbosacral plexopathy should be included in the differential diagnosis of such cases, presenting with sudden leg weakness.
- Open Access
- 16 December 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1447432
Electromyography findings in L5 radiculopathy are not associated with fatty infiltration of paraspinal muscles: a retrospective observational study
Introduction: Increased fatty infiltration of the paraspinal muscles (PM) has been recognized as a sign of decreased muscle quality in patients with degenerative disc disease. However, whether fatty infiltration is a consequence of a neurogenic process due to spinal nerve root compression has not yet been determined.Objective: To investigate the correlation between fatty infiltration of the paraspinal muscles (PM) and neurogenic remodeling of motor unit action potentials (MUAPs) in patients with lumbar radiculopathy.Materials and methods: 58 adult patients (32 women) with L5 radiculopathy caused by an L4-L5 herniated disc were examined. We compared the neurological status, EMG data of the PM at the L5 level on the affected side and the L4 level on the opposite side of the spine, and the severity of fatty infiltration of the PM assessed on axial T2-weighted magnetic resonance imaging (MRI) scans.Results: We did not find any correlation between the degree of fatty infiltration and neurogenic remodeling of MUAPs in the PM.Conclusion: The lack of correlation between the degree of fatty infiltration and the presence of neurogenic remodeling of MUAPs in the PM suggests that fatty infiltration and neuropathic changes in muscles may be considered as separate processes requiring further research.
- 16 December 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1447432
Open AccessElectromyography findings in L5 radiculopathy are not associated with fatty infiltration of paraspinal muscles: a retrospective observational study
Introduction: Increased fatty infiltration of the paraspinal muscles (PM) has been recognized as a sign of decreased muscle quality in patients with degenerative disc disease. However, whether fatty infiltration is a consequence of a neurogenic process due to spinal nerve root compression has not yet been determined.Objective: To investigate the correlation between fatty infiltration of the paraspinal muscles (PM) and neurogenic remodeling of motor unit action potentials (MUAPs) in patients with lumbar radiculopathy.Materials and methods: 58 adult patients (32 women) with L5 radiculopathy caused by an L4-L5 herniated disc were examined. We compared the neurological status, EMG data of the PM at the L5 level on the affected side and the L4 level on the opposite side of the spine, and the severity of fatty infiltration of the PM assessed on axial T2-weighted magnetic resonance imaging (MRI) scans.Results: We did not find any correlation between the degree of fatty infiltration and neurogenic remodeling of MUAPs in the PM.Conclusion: The lack of correlation between the degree of fatty infiltration and the presence of neurogenic remodeling of MUAPs in the PM suggests that fatty infiltration and neuropathic changes in muscles may be considered as separate processes requiring further research.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 22 (2)
Calcitonin gene-related peptide in pathophysiology of migraine
Migraine is one of the most common neurological diseases manifested by headache attacks. Calcitonin-gene related peptide (CGRP) plays a key role in the pathophysiology of migraine. The release of CGRP during a migraine attack leads to cranial vasodilation and neurogenic inflammation. As a result, the sensory fibres of the trigeminal nerve become activated and the transmission of pain impulses to the brain is modulated. Due to the wide representation of CGRP receptors in the brain, the calcitonin-gene related peptide is an actively studied target in studies of antimigraine drugs. This review presents the mechanisms of action, a description of the structure, receptors of the calcitonin gene-related peptide in the pathophysiology of migraine and demonstrates new therapeutic options related to CGRP.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 22 (2)
Calcitonin gene-related peptide in pathophysiology of migraine
Migraine is one of the most common neurological diseases manifested by headache attacks. Calcitonin-gene related peptide (CGRP) plays a key role in the pathophysiology of migraine. The release of CGRP during a migraine attack leads to cranial vasodilation and neurogenic inflammation. As a result, the sensory fibres of the trigeminal nerve become activated and the transmission of pain impulses to the brain is modulated. Due to the wide representation of CGRP receptors in the brain, the calcitonin-gene related peptide is an actively studied target in studies of antimigraine drugs. This review presents the mechanisms of action, a description of the structure, receptors of the calcitonin gene-related peptide in the pathophysiology of migraine and demonstrates new therapeutic options related to CGRP.
- 11 March 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (2) , 116-122
Rehabilitation of patients with facial nerve neuropathy in cases of increased muscle tone on the healthy side of the face
OBJECTIVE To evaluate the effectiveness of physical rehabilitation (PR) and injections of botulinum toxin type A (BTA) in the correction of muscles hypertonicity ty of the healthy side of the face or its prevention in patients with facial nerve neuropathy (FNN). MATERIAL AND METHODS One hundred and forty-six patients with FNN of various etiologies with muscles hypertonicity of the healthy side or the risk of its development were studied. The term of treatment was 33 [10; 99] days. There are 88 women and 58 men aged 42 [34; 56] years. Diagnosis included clinical examination and stimulation electroneuromyography (ENMG, n=113; 77.4%) with assessment of M-wave amplitude asymmetry. All patients were prescribed a standard PR complex, in addition — relaxation of the muscles of the healthy side by injections of BTA (Incobotulinumtoxin A) — BTA group (n=38) or by special PR techniques — physiotherapy group (n=108). RESULTS In both groups, patients were comparable in age, sex and severity of FNN at clinical assessment. But objectively, in the BTA group there were more symptomatic forms (63.2% vs 43.5%; p=0.038), cases of M-wave amplitude asymmetry over 90% in ≥2 branches (52.6% vs 18.5%; p=0.032). Displacement of the face midline was a factor limiting recovery (68.4% and 62%; χ2=0.495; p=0.482) in two groups. With amplitude asymmetry of more than 90% in ≥2 branches (a predictor of the risk of unfavorable outcome), a favorable outcome occurred more often in the BTA group (80% versus 45%; χ2=5.227; p=0.023). In case of amplitude asymmetry of less than 90% in all branches, a favorable outcome was observed in two groups. CONCLUSION Indications for botulinum therapy in patients with FNN are deep prosoparesis or prosoplegia, muscles hypertonicity of the healthy side, displacement of the face midline, ENMG predictors of the risk of unfavorable outcome. PR is an effective method of prevention in patients with a favorable prognosis of outcome or treatment of mild forms.
- 11 March 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (2) , 116-122
Rehabilitation of patients with facial nerve neuropathy in cases of increased muscle tone on the healthy side of the face
OBJECTIVE To evaluate the effectiveness of physical rehabilitation (PR) and injections of botulinum toxin type A (BTA) in the correction of muscles hypertonicity ty of the healthy side of the face or its prevention in patients with facial nerve neuropathy (FNN). MATERIAL AND METHODS One hundred and forty-six patients with FNN of various etiologies with muscles hypertonicity of the healthy side or the risk of its development were studied. The term of treatment was 33 [10; 99] days. There are 88 women and 58 men aged 42 [34; 56] years. Diagnosis included clinical examination and stimulation electroneuromyography (ENMG, n=113; 77.4%) with assessment of M-wave amplitude asymmetry. All patients were prescribed a standard PR complex, in addition — relaxation of the muscles of the healthy side by injections of BTA (Incobotulinumtoxin A) — BTA group (n=38) or by special PR techniques — physiotherapy group (n=108). RESULTS In both groups, patients were comparable in age, sex and severity of FNN at clinical assessment. But objectively, in the BTA group there were more symptomatic forms (63.2% vs 43.5%; p=0.038), cases of M-wave amplitude asymmetry over 90% in ≥2 branches (52.6% vs 18.5%; p=0.032). Displacement of the face midline was a factor limiting recovery (68.4% and 62%; χ2=0.495; p=0.482) in two groups. With amplitude asymmetry of more than 90% in ≥2 branches (a predictor of the risk of unfavorable outcome), a favorable outcome occurred more often in the BTA group (80% versus 45%; χ2=5.227; p=0.023). In case of amplitude asymmetry of less than 90% in all branches, a favorable outcome was observed in two groups. CONCLUSION Indications for botulinum therapy in patients with FNN are deep prosoparesis or prosoplegia, muscles hypertonicity of the healthy side, displacement of the face midline, ENMG predictors of the risk of unfavorable outcome. PR is an effective method of prevention in patients with a favorable prognosis of outcome or treatment of mild forms.